Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
Sales | 24,610 | 27,140 | 26,660 | 23,890 | 16,440 |
Pre-tax Income | 24,610 | 27,140 | 26,660 | 23,890 | 16,440 |
Other Income | 24,610 | 27,140 | 26,660 | 23,890 | 16,440 |
Net Income | $24,610 | $27,140 | $26,660 | $23,890 | $16,440 |
EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |